JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 2 242-249
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Signore, A.
Right arrow Articles by Biancone, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Signore, A.
Right arrow Articles by Biancone, L.

123I-Interleukin-2 Scintigraphy for In Vivo Assessment of Intestinal Mononuclear Cell Infiltration in Crohn's Disease

Alberto Signore, Marco Chianelli, Alessio Annovazzi, Elena Bonanno, Luigi G. Spagnoli, Paolo Pozzilli, Francesco Pallone and Livia Biancone

Department of Clinical Sciences, University "La Sapienza", Rome
Institute of Anatomic Pathology, Department of Biopathology and Imaging Diagnostic, University "Tor Vergata", Rome, Italy

Correspondence: For correspondence or reprints contact: Alberto Signore, MD, Nu.M.E.D. Group, Dipartimento Scienze Cliniche, Policlinico Umberto I, 00161 Roma, Italy.

ABSTRACT

Activated mononuclear cells expressing interteukin-2 (IL2) receptors (IL2-Rs) heavily infiltrate the Crohn's disease (CD) gut wall. A new technique for the in vivo detection of tissue infiltrating IL2-R positive (IL2R+ve) cells was developed based on 123I-IL2 scintigraphy. The aim of this study was to investigate whether 123I-IL2 accumulates in the CD gut wall in different phases of the disease and to evaluate the specificity of 123I-IL2 binding to activated IL2R+ve cells infiltrating the gut wall. Methods: Fifteen patients with ileal CD (10 active and 5 inactive) and 10 healthy volunteers were studied by 123I-IL2 scintigraphy. Six patients with active CD were studied before and after 12 wk of steroid treatment. After scintigraphy, patients were followed up for 29–54 mo. Ex vivo autoradiography was performed to determine specificity of 125I-IL2 binding to IL2R+ve cells. For bowel scintigraphy, 123I-IL2 (75 MBq) was injected intravenously and {gamma} camera images were acquired after 1 h. Bowel radioactivity was quantified in 64 regions of interest (ROIs). Results: Autoradiography showed specific binding of 125I-IL2 to IL2R+ve mononuclear cells infiltrating the CD gut wall. Intestinal 123I-IL2 uptake assessed by the number of positive ROIs was higher in patients with active or inactive CD than in healthy volunteers (P < 0.0001 and P = 0.03, respectively) and positively correlated with the CD activity index (P = 0.01). 123I-IL2 intestinal uptake significantly decreased in patients with CD in steroid-induced remission (P = 0.03). A significant correlation was observed between the number of positive ROIs and time to disease relapse. Conclusion: 123I-IL2 accumulates in the diseased CD gut wall by specific binding to IL2R+ve cells, infiltrating the involved tissues. 123I-IL2 scintigraphy may be an objective tool for the in vivo assessment of intestinal activated mononuclear cell infiltration.

Key Words: Crohn's disease • mucosal lymphocytes • interleukin-2 • scintigraphy




This article has been cited by other articles:


Home page
JNMHome page
S. Gratz, H. J.J.M. Rennen, O. C. Boerman, W. J.G. Oyen, and F. H.M. Corstens
Rapid Imaging of Experimental Colitis with 99mTc-Interleukin-8 in Rabbits
J. Nucl. Med., June 1, 2001; 42(6): 917 - 923.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.